or Try an Advanced Search...

    Technical Analysis for SONN - SONNET BioTherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 4.32 -4.64% -0.21
    SONN closed down 4.64 percent on Friday, November 1, 2024, on 61 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SONN trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Calm After Storm Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Calm After Storm Range Contraction -4.64%
    NR7 Range Contraction -4.64%
    Narrow Range Bar Range Contraction -4.64%
    Stochastic Reached Oversold Weakness -4.64%
    Wide Bands Range Expansion -4.64%
    Older End-of-Day Signals for SONN ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 17 hours ago
    Down 3% about 20 hours ago
    Fell Below Previous Day's Low about 20 hours ago
    Down 2 % about 20 hours ago
    Down 1% about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SONN Chart by TradingView
    Basic chart:

    Profile

    SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Biology Immunology Antibody Cytokine Blood Plasma Biochemistry

    Is SONN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 28 Sonnet stock tumbles 22% in wake of proposed offering filing
    Oct 10 Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
    Oct 4 Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
    Sep 30 Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
    Sep 25 Sonnet BioTherapeutics to execute 1-for-8 reverse stock split
    Sep 25 Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
    Sep 4 Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series
    Aug 19 Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
    Aug 14 Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
    Jul 24 Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
    See more SONN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.7192
    52 Week Low 4.14
    Average Volume 27,126
    200-Day Moving Average 10.36
    50-Day Moving Average 5.98
    20-Day Moving Average 5.19
    10-Day Moving Average 5.31
    Average True Range 0.62
    RSI (14) 35.06
    ADX 24.67
    +DI 16.52
    -DI 29.98
    Chandelier Exit (Long, 3 ATRs) 4.64
    Chandelier Exit (Short, 3 ATRs) 6.01
    Upper Bollinger Bands 6.49
    Lower Bollinger Band 3.88
    Percent B (%b) 0.17
    BandWidth 50.18
    MACD Line -0.34
    MACD Signal Line -0.24
    MACD Histogram -0.0997
    Fundamentals Value
    Market Cap 13.26 Million
    Num Shares 3.07 Million
    EPS -18.14
    Price-to-Earnings (P/E) Ratio -0.24
    Price-to-Sales 29.80
    Price-to-Book 19.07
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.65
    Resistance 3 (R3) 4.66 4.57 4.60
    Resistance 2 (R2) 4.57 4.48 4.56 4.58
    Resistance 1 (R1) 4.44 4.43 4.40 4.43 4.56
    Pivot Point 4.35 4.35 4.32 4.34 4.35
    Support 1 (S1) 4.22 4.26 4.18 4.21 4.08
    Support 2 (S2) 4.13 4.21 4.12 4.06
    Support 3 (S3) 4.00 4.13 4.05
    Support 4 (S4) 3.99